ZimVie Inc.

Equities

ZIMV

US98888T1079

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
15.82 ^USD	+2.20%		+2.53%	-10.87%

Apr. 01	H.I.G. Capital, LLC completed the acquisition of Zimmer Biomet Spine, Inc. from ZimVie Inc..	CI
Mar. 18	ZimVie Inc.(NasdaqGS:ZIMV) added to S&P Healthcare Equipment Select Industry Index	CI

ZimVie Inc. Provides Earnings Guidance for First Quarter and Raises Earnings Guidance for the Full Year 2024

February 28, 2024 at 04:11 pm EST

ZimVie Inc. provided earnings guidance for first quarter and raised earnings guidance for the full year 2024. For Projected Quarter Ending March31, 2024, Company expects Net Sales of Continuing Operations to be $115 million - $118 million.

For the year, the company expects net sales to be $455 million plus.

Latest news about ZimVie Inc.

H.I.G. Capital, LLC completed the acquisition of Zimmer Biomet Spine, Inc. from ZimVie Inc..	Mar. 31	CI
ZimVie Inc.(NasdaqGS:ZIMV) added to S&P Healthcare Equipment Select Industry Index	Mar. 17	CI
Barclays Adjusts Price Target on ZimVie to $16 From $13, Maintains Underweight Rating	Mar. 05	MT
Transcript : ZimVie Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
ZimVie Inc. Provides Earnings Guidance for First Quarter and Raises Earnings Guidance for the Full Year 2024	Feb. 28	CI
ZimVie Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
(ZIMV) ZIMVIE Expects Q1 Revenue Range $115M - $118M	Feb. 28	MT
Earnings Flash (ZIMV) ZIMVIE Reports Q4 Revenue $113.1M	Feb. 28	MT
Earnings Flash (ZIMV) ZIMVIE Reports Q4 EPS $0.11, vs. Street Est of $0.13	Feb. 28	MT
ZimVie Inc. Announces Launch of Next-Generation TSX®? Implant in Japan	Feb. 07	CI
Top Midday Gainers	Dec. 18	MT
ZimVie to Sell Spine Business to H.I.G. Capital for $375 Million; Shares Rise	Dec. 18	MT
H.I.G. Capital, LLC entered into an Equity Purchase Agreement to acquire Zimmer Biomet Spine, Inc. from ZimVie Inc. for approximately $380 million.	Dec. 17	CI
ZimVie Inc. Announces Compatibility Between Its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation	Dec. 12	CI
Needham Starts ZimVie With Hold Rating	Nov. 16	MT
Top Premarket Decliners	Nov. 02	MT
Transcript : ZimVie Inc., Q3 2023 Earnings Call, Nov 01, 2023	Nov. 01
(ZIMV) ZIMVIE Forecasts Fiscal Year 2023 EPS Range $0.60 - $0.70	Nov. 01	MT
Earnings Flash (ZIMV) ZIMVIE Reports Q3 Revenue $202.9M, vs. Street Est of $196M	Nov. 01	MT
Earnings Flash (ZIMV) ZIMVIE Posts Q3 EPS $0.08, vs. Street Est of $-0.02	Nov. 01	MT
Zimvie Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023	Nov. 01	CI
ZimVie Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
ZimVie Inc. Announces First U.S. Surgery with the 4.5mm Mobi-C(R) Cervical Disc	23-10-31	CI
ZimVie Inc. Announces the Launch of Azure Multi-Platform Product Solutions	23-10-17	CI
ZimVie Inc. Announces the Recent Launch of Biotivity A/C Plus Membrane	23-10-10	CI

Chart ZimVie Inc.

Duration

Period

More charts

Company Profile

ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

15.82 USD

Average target price

16 USD

Spread / Average Target

+1.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
ZIMVIE INC.	-10.87%	431M
SHOCKWAVE MEDICAL, INC.	+73.17%	12.38B
PENUMBRA, INC.	-18.74%	7.92B
MASIMO CORPORATION	+16.15%	7.2B
GETINGE AB	+4.81%	5.84B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+5.99%	5.07B
APT MEDICAL INC.	+27.07%	4.53B
ASAHI INTECC CO., LTD.	-21.67%	3.88B
INARI MEDICAL, INC.	-40.82%	2.23B
SKAN GROUP AG	+1.49%	2.02B

Medical Equipment